Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
July 1, 2025
Monotherapy with upstream or alternative pathway inhibitors
Catherine M Broome
Clinical Advances in Hematology & Oncology : H&O
|
April 11, 2019
Diagnosis and treatment of cold agglutinin disease
Catherine M Broome
Clinical Advances in Hematology & Oncology : H&O
|
July 1, 2025
Dual therapy: danicopan as add-on therapy to C5 inhibitors
Catherine M Broome
Expert Review of Hematology
|
May 31, 2023
Complement-directed therapy for cold agglutinin disease: sutimlimab
Catherine M Broome
Clinical Advances in Hematology & Oncology : H&O
|
July 1, 2025
Practical approach to managing PNH: Q&A
Gloria F Gerber, Ilene C Weitz, Catherine M Broome
Clinical Advances in Hematology & Oncology : H&O
|
April 20, 2013
Safe and effective treatment of aggressive non-hodgkin lymphoma with rituximab and bendamustine in patients with severe liver impairment
James K McCloskey, Catherine M Broome, Bruce D Cheson
Clinical Advances in Hematology & Oncology : H&O
|
July 1, 2025
Navigating the paroxysmal nocturnal hemoglobinuria (PNH) landscape
Gloria F Gerber, Catherine M Broome, Ilene C Weitz
Lancet (London, England)
|
August 3, 2024
Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial - Authors' reply
Hanny Al-Samkari, James B Bussel, Yoshi Miyakawa, et al.
American Journal of Hematology
|
March 9, 2024
The latest insights into rare blood disorders: Diagnosis and treatment strategies
David J Kuter, Spero R Cataland, Catherine M Broome, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2002
Phase II trial of weekly paclitaxel in patients with previously treated advanced urothelial cancer
David J Vaughn, Catherine M Broome, Maha Hussain, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Clinical Advances in Hematology & Oncology : H&O
|
July 1, 2025
Monotherapy with upstream or alternative pathway inhibitors
Catherine M Broome
Clinical Advances in Hematology & Oncology : H&O
|
April 11, 2019
Diagnosis and treatment of cold agglutinin disease
Catherine M Broome
Clinical Advances in Hematology & Oncology : H&O
|
July 1, 2025
Dual therapy: danicopan as add-on therapy to C5 inhibitors
Catherine M Broome
Expert Review of Hematology
|
May 31, 2023
Complement-directed therapy for cold agglutinin disease: sutimlimab
Catherine M Broome
Clinical Advances in Hematology & Oncology : H&O
|
July 1, 2025
Practical approach to managing PNH: Q&A
Gloria F Gerber, Ilene C Weitz, Catherine M Broome
Clinical Advances in Hematology & Oncology : H&O
|
April 20, 2013
Safe and effective treatment of aggressive non-hodgkin lymphoma with rituximab and bendamustine in patients with severe liver impairment
James K McCloskey, Catherine M Broome, Bruce D Cheson
Clinical Advances in Hematology & Oncology : H&O
|
July 1, 2025
Navigating the paroxysmal nocturnal hemoglobinuria (PNH) landscape
Gloria F Gerber, Catherine M Broome, Ilene C Weitz
Lancet (London, England)
|
August 3, 2024
Efgartigimod for primary immune thrombocytopenia: the ADVANCE IV trial - Authors' reply
Hanny Al-Samkari, James B Bussel, Yoshi Miyakawa, et al.
American Journal of Hematology
|
March 9, 2024
The latest insights into rare blood disorders: Diagnosis and treatment strategies
David J Kuter, Spero R Cataland, Catherine M Broome, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 15, 2002
Phase II trial of weekly paclitaxel in patients with previously treated advanced urothelial cancer
David J Vaughn, Catherine M Broome, Maha Hussain, et al.
Page
of 3